Effective or announced 7 February 2026Impact for foreign investors: medium
What changed
Under the framework for an interim trade agreement announced on 7 February 2026, the US was to apply an 18% reciprocal tariff to Indian-origin goods. India was to address non-tariff barriers, including for US medical devices.
Who it affects
Exporters from India to the US, US medical-device makers selling into India, and groups planning India as an export base.
What to do
Confirm the current tariff and the agreement’s status before relying on these terms in pricing or location decisions.